Prodromes and predictors of migraine attack

Functional Neurology

Volumn 20, Issue 4, 2005, Pages 185-191

  Rossi, Paolo ^a,b   Ambrosini, Anna ^c   Buzzi, M Gabriella ^d  

^a INI Grottaferrata   (Italy)

^b Polyclinic of Monza   (Italy)

^c IRCCS NEUROMED   (Italy)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Epidemiology; Migraine; Pathogenesis; Premonitory symptoms

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CLINICAL FEATURE; COMORBIDITY; DRUG TARGETING; ELECTROENCEPHALOGRAM; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HEADACHE; HEREDITY; MEDICAL LITERATURE; MEDICAL RESEARCH; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NEUROPHYSIOLOGY; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PREDICTION; PREMENSTRUAL SYNDROME; PREVALENCE; RELIABILITY; STATISTICAL SIGNIFICANCE; SYMPTOM; TREATMENT RESPONSE;

HUMANS; MIGRAINE DISORDERS; PREDICTIVE VALUE OF TESTS;

EID: 33645047898     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gowers WR. A Manual of Diseases of the Nervous System. Philadelphia; P. Blakiston, Son & Co, 1888
2. Isler H. Frequency and course of premonitory phenomena. In: Amery WK, Waquir A eds The Prelude to the Migraine Attack. London; Baillière Tindall 1986:44-53
3. Headache Classification of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (Suppl 7): 1-96
4. Blau JN. Migraine prodromes separated from the aura: complete migraine. Br Med J 1980;281:658-660
5. Lance JW. What is migraine? In: Critchley M et al. eds Advances in Neurology. New York; Raven Press 1982;33:21-26
6. Waelkens J. Warning symptoms in migraine: characteristics and therapeutic implications. Cephalalgia 1985;5:223-228
7. Amery WK, Waelkens J, Vandenbergh V. Migraine warnings. Headache 1986;26:60-66
8. Amery WK, Waelkens J. Prevention of the last chance: an alternative pharmacologic treatment of migraine. Headache 1983;23:37-38
9. Waelkens J. Dopamine blockade with domperidone: bridge between prophylactic and abortive treatment of migraine? A dose-finding study. Cephalalgia 1984;4:85-90
10. Giffin NJ, Ruggiero L, Lipton RB et al. Premonitory symptoms in migraine: an electronic diary study. Neurology 2003; 60:935-940
11. Afridi SK, Kaube H, Goadsby PJ. Glyceryl trinitrate triggers premonitory symptoms in migraine. Pain 2004;110:675-680
12. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders (second edition). Cephalalgia 2004; 24:1-160
13. Zagami A, Rasmussen BK. Symptomatology of migraine without aura. In: Olesen J, Tfelt-Hansen P, Welch KMA eds The Headaches, 2nd edn. Philadelphia; Lippincott, Williams & Wilkins 2000:337-338
14. Santoro G, Bernasconi F, Sessa F, Venco A. Premonitory symptoms in migraine without aura: a clinical investigation. Funct Neurol 1990;5:339-344
15. Rasmussen BK, Olesen J. Migraine with aura and without aura: an epidemiological study. Cephalalgia 1992;12:221-228
16. Russel MB, Rasmussen BK, Fenger K, Olesen J. Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia 1996;16:239-245
17. Dahlof C, Linde M. One-year prevalence of migraine in Sweden: a population-based study in adults. Cephalalgia 2001;21:664-671
18. Silberstein SD, Saper JR, Freitag FG. Migraine diagnosis and treatment. In: Silberstein SD, Lipton RB, Dalessio DJ, eds Wolff's Headache and Other Head Pain. Seventh Edition. 2001:121-137
19. Cady R, Schreiber C, Farmer K, Sheftell F. Primary headaches: a convergence hypothesis. Headache 2002; 42:204-216
20. Kelman L. The premonitory symptoms (prodrome): a tertiary care study of 893 migraineurs. Headache 2004;44:865-872
21. Harrigan J, Kues J, Ricks D, Smith R. Moods that predict coming migraine headache. Pain 1984;20:382-396
22. Rozen TD. Migraine prodrome: a nose on a face. Lancet 2004;363:517
23. Schoonman GG, Evers DJ, van Dijk JG, Ferrari MD. Sensitivity and predictive value of trigger factors and premonitory symptoms in migraine. Cephalaigia 2003;23:596 (abstract)
24. Kropp P, Gerber WD. Prediction of migraine attacks using a slow cortical potential, the contingent negative variation. Neurosci Lett 1998;257:73-76
25. Evers S, Quidelbey F, Grotemeyer KH, Suhr B, Husstedt JW. Dynamic changes of cognitive habituation and serotonin metabolism during the migraine interval. Cephalalgia 1999;19:485-491
26. Siniatchkin M, Gerber WD, Kropp P, Vein A. How the brain anticipates an attack: a study of neurophysiological periodicity in migraine. Funct Neurol 1999;14:69-77
27. Kropp P, Siniatchkin M, Gerber WD. On the pathophysiology of migraine - links for "empirically based treatment" with neurofeedback. Appl Psychophysiol Biofeedback 2002; 27:203-213
28. De Marinis M, Pujia A, Natale L, D'Arcangelo E, Accornero N. Decreased habituation of the R2 component of the blink reflex in migraine patients. Clin Neurophysiol 2003;114: 889-893
29. Rasmussen BK. Migraine and tension-type headache in the general population: precipitating factors, females hormones, sleep pattern and relation to lifestyle. Pain 1993; 53:65-72
30. Kececi H, Dener S. Epidemiology and clinical characteristics of migraine in Sivas, Turkey. Headache 2002;42:275-280
31. Ho KH, Ong BK. A community-based study of headache diagnosis and prevalence in Singapore. Cephalalgia 2003; 23:6-13
32. Takeshima T. Ishikazi K, Fukuhara Y et al. Population-based, door-to-door survey of migraine in Japan: Daisen study Headache 2004;44:8-19
33. Jensen R, Bendtsen L. Is chronic daily headache a useful diagnosis? J Headache Pain 2004;5:87-93
34. Blau JN, Engel HO. Premonitory and prodromal symptoms in cluster headache. Cephalalgia 1998;18:91-93
35. Raimondi E. Cluster headache. Premonitory symptoms. Headache 1999;39:565-566
36. Del Zompo M, Cherchi A, Palmas MA et al. Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 1998;51:781-786
37. Hargreaves RJ, Shepheard SL. Pathophysiology of migraine. New insights. Can J Neurol Sci 1999; 26 (Suppl 3): S12-S19
38. Goadsby PJ, Lipton RB, Ferrari MD. Migraine. Current understanding and treatment. N Engl J Med 2002;346:257-268
39. Nappi G, Rossi P. Pathophysiology of migraine. In Nappi G, Rossi P eds Migraine. Current Concepts. London; Current Medical Literature 2004:54-64
40. Milian MJ. Descending control of pain. Prog Neurobiol 2002; 66:355-474
41. Cervero F, Laird JM. Visceral pain. Lancet 1999;353:2145-2148